chr13-95709306-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_006260.5(DNAJC3):āc.162T>Gā(p.Ala54=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00141 in 1,590,026 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00092 ( 0 hom., cov: 32)
Exomes š: 0.0015 ( 3 hom. )
Consequence
DNAJC3
NM_006260.5 synonymous
NM_006260.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0540
Genes affected
DNAJC3 (HGNC:9439): (DnaJ heat shock protein family (Hsp40) member C3) This gene encodes a protein with multiple tetratricopeptide repeat (TPR) motifs as well as the highly conserved J domain found in DNAJ chaperone family members. It is a member of the tetratricopeptide repeat family of proteins and acts as an inhibitor of the interferon-induced, dsRNA-activated protein kinase (PKR). [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 13-95709306-T-G is Benign according to our data. Variant chr13-95709306-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 724566.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-95709306-T-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.054 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000919 (140/152346) while in subpopulation NFE AF= 0.00176 (120/68020). AF 95% confidence interval is 0.00151. There are 0 homozygotes in gnomad4. There are 63 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJC3 | NM_006260.5 | c.162T>G | p.Ala54= | synonymous_variant | 2/12 | ENST00000602402.6 | NP_006251.1 | |
DNAJC3 | XM_011521104.3 | c.162T>G | p.Ala54= | synonymous_variant | 2/13 | XP_011519406.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJC3 | ENST00000602402.6 | c.162T>G | p.Ala54= | synonymous_variant | 2/12 | 1 | NM_006260.5 | ENSP00000473631 | P1 | |
DNAJC3 | ENST00000376795.6 | c.162T>G | p.Ala54= | synonymous_variant | 2/11 | 5 | ENSP00000365991 |
Frequencies
GnomAD3 genomes AF: 0.000913 AC: 139AN: 152228Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
139
AN:
152228
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00135 AC: 319AN: 235456Hom.: 0 AF XY: 0.00135 AC XY: 173AN XY: 127976
GnomAD3 exomes
AF:
AC:
319
AN:
235456
Hom.:
AF XY:
AC XY:
173
AN XY:
127976
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00146 AC: 2106AN: 1437680Hom.: 3 Cov.: 30 AF XY: 0.00139 AC XY: 995AN XY: 714660
GnomAD4 exome
AF:
AC:
2106
AN:
1437680
Hom.:
Cov.:
30
AF XY:
AC XY:
995
AN XY:
714660
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000919 AC: 140AN: 152346Hom.: 0 Cov.: 32 AF XY: 0.000845 AC XY: 63AN XY: 74520
GnomAD4 genome
AF:
AC:
140
AN:
152346
Hom.:
Cov.:
32
AF XY:
AC XY:
63
AN XY:
74520
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | DNAJC3: BP4, BP7 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 23, 2018 | - - |
DNAJC3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 18, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at